Cite Filings / CTEV / 0001172661-25-005209
Feed Companies Filings Check
Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Claritev Corp · Filed 2025-11-19 · Acc 0001172661-25-005209

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-11-20 4 Pres., CEO & Executive Chair bought 5,290 shares at $47.23 ($249,842)
  • 2025-11-19 4 SVP, Chief Strategy Officer bought 916 shares at $38.00 ($34,808)
  • 2025-11-19 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-11-18 4 SVP, General Counsel bought 625 shares at $38.84 ($24,273)
  • 2025-11-18 4 EVP, Chief Digital Officer bought 9,600 shares at $38.25 ($367,199)
  • 2025-11-14 4 10% owner sold 1,500,000 shares at $48.67 ($73,001,250)
  • 2025-01-03 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2025-11-14 SCHEDULE 13D/A · Hellman & Friedman Investors VIII, L.P. 23.5%
  2. 2025-01-16 SCHEDULE 13D/A · Green Equity Investors VI, L.P. 4.8%
  3. 2024-11-12 SC 13G/A · The Vanguard Group 2.06%
  4. 2024-11-04 SC 13G/A · The Vanguard Group 2.06%
  5. 2024-11-04 SC 13G/A · The Vanguard Group 2.06%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…